Alongside a preventive supplementation with nutraceuticals, therapies used for wet AMD aim to inhibit abnormal growth of blood vessels with laser photocoagulation or vascular endothelial growth factor (VEGF) inhibitors that are injected into the eye; however, some side effects and progression of AMD have been observed, and anti-VEGF-A therapies do not reverse vision quality. The gene discussed is VEGFA; the disease is age-related macular degeneration.